menu
    • menu

    Company profile for Alteogen

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2008, Alteogen is a leading bio company whose portfolio includes next-generation Biobetter, with improved efficacy in comparison with existing biologics, biosimilars that demonstrate “comparability” to the existing biologics, and proprietary biologics. Alteogen focus on the three cutting edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate, and antibody biosimilars with comp...
    Founded in 2008, Alteogen is a leading bio company whose portfolio includes next-generation Biobetter, with improved efficacy in comparison with existing biologics, biosimilars that demonstrate “comparability” to the existing biologics, and proprietary biologics. Alteogen focus on the three cutting edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate, and antibody biosimilars with complexity. Currently, Alteogen has developed NexP™ Fusion Technology, a next-generation long-acting biobetter technology on its own, developed NexMab™ ADC Technology, an Antibody-Drug Conjugate technology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alteogenkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, 34054
    Telephone
    Telephone
    +82-42-384-8780
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.alteogen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alteogen
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Gets EU Approval For First Subcutaneous Cancer Treatment,
    Merck Gets EU Approval For First Subcutaneous Cancer Treatment,

    21 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/merck-receives-eu-nod-for-first-subcutaneous-formulation-promising-faster-cancer-treatment-18291

    INDPHARMAPOST
    21 Nov 2025
    Share Share
    Alteogen Gets EU Approval for Aflibercept Biosimilar Eyluxvi
    Alteogen Gets EU Approval for Aflibercept Biosimilar Eyluxvi

    17 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alteogen-receives-european-commission-approval-for-aflibercept-biosimilar-eyluxvi-alt-l9-302558913.html

    PR NEWSWIRE
    17 Sep 2025
    Share Share
    CHMP Backs Alteogen’s Aflibercept Biosimilar EYLUXVI (ALT-L9)
    CHMP Backs Alteogen’s Aflibercept Biosimilar EYLUXVI (ALT-L9)

    28 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alteogen-receives-positive-chmp-opinion-for-aflibercept-biosimilar-eyluxvi-alt-l9-302514688.html

    PR NEWSWIRE
    28 Jul 2025
    Share Share
    AstraZeneca signs Alteogen deal worth up to $1.35B
    AstraZeneca signs Alteogen deal worth up to $1.35B

    19 Mar 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-signs-135b-alteogen-deal-subcutaneous-cancer-drugs-despite-merck-halozyme-patent

    FIERCE PHARMA
    19 Mar 2025
    Share Share
    Daiichi Sankyo partners Alteogen on subcutaneous Enhertu News
    Daiichi Sankyo partners Alteogen on subcutaneous Enhertu News

    09 Nov 2024

    // PHARMAPHORUM

    https://pharmaphorum.com/news/daiichi-sankyo-partners-alteogen-subcutaneous-enhertu

    PHARMAPHORUM
    09 Nov 2024
    Share Share
    Alteogen's Tergase Shows Excellent Immunogenicity Profile
    Alteogen's Tergase Shows Excellent Immunogenicity Profile

    05 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alteogens-tergase-novel-recombinant-human-hyaluronidase-injection-shows-excellent-immunogenicity-profile-301916724.html

    PR NEWSWIRE
    05 Sep 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search